Compound information
- Natural Products
- ZC3271764
- Molecular Formula
- C21H20F6N2O3
- Molecular Weight
- 462.13781182 g/mol
- Structure
-
- IUPAC Name
- [2,2,2-trifluoro-1-(trifluoromethyl)ethyl] 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate
- InChI
- InChI=1S/C21H20F6N2O3/c22-20(23,24)18(21(25,26)27)32-19(30)29-11-9-28(10-12-29)14-15-5-4-8-17(13-15)31-16-6-2-1-3-7-16/h1-8,13,18H,9-12,14H2
- InChI Key
- AVSCNEOUWSVZEY-UHFFFAOYSA-N
- SMILES
- O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2cccc(Oc3ccccc3)c2)CC1
- Source
- ZINC000095705051
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 32 | Ring Count | 3 |
Heteroatom Count | 11 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 42.01 Å2 | LogP | 4.838 |
LogS | -5.265 | LogD | 4.086 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.056 | Pgp substrate | 0.004 |
HIA | 0.964 | F20 % | 0.98 |
F30 % | 0.968 | Caco-2 | -4.812 |
MDCK | -4.708 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.902 | PPB | 98.48 |
VD | 2.7 | Fu | 2.384 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.053 | CYP1A2 substrate | 0.633 |
CYP2A6 substrate | 0.807 | CYP2B6 substrate | 0.687 |
CYP2C19 inhibitor | 0.884 | CYP2C19 substrate | 0.853 |
CYP2C8 substrate | 0.688 | CYP2C9 inhibitor | 0.835 |
CYP2C9 substrate | 0.998 | CYP2D6 inhibitor | 0.92 |
CYP2D6 substrate | 0.941 | CYP2E1 substrate | 0.833 |
CYP3A4 inhibitor | 0.063 | CYP3A4 substrate | 0.989 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.207 | CL | 6.285 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.923 | Hepatotoxicity | 0.619 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.524 |
FDAMDD | 0.992 | Skin Sensitization | 0.706 |
Carcinogenicity | 0.039 | Eye Corrosion | 0.0 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.857 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.735 | IGC50 | 4.555 |
LC50FM | 4.897 | LC50DM | 6.871 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.39 | NR-AR-LBD | 0.265 |
NR-AhR | 0.065 | NR-Aromatase | 0.168 |
NR-ER | 0.261 | NR-ER-LBD | 0.478 |
NR-PPAR-gamma | 0.144 | SR-ARE | 0.809 |
SR-ATAD5 | 0.283 | SR-HSE | 0.253 |
SR-MMP | 0.032 | SR-p53 | 0.118 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.